The University of Chicago Header Logo

Connection

Ravi Salgia to L-Lactate Dehydrogenase

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about L-Lactate Dehydrogenase.
Ravi Salgia
Connection Strength
0.033
L-Lactate Dehydrogenase
  1. A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1). Ann Oncol. 2015 Aug; 26(8):1741-8.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.